Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: slide ring gel

golf balls on tees in the green grass
September 10, 2026 Non-pharma applications / Other industrial use

Cyclodextrins hit the golf course seven years ago — and they are still there

Golf balls may look simple, but they are highly engineered products. Their performance depends on carefully designed combinations of cores,

Continue reading

August 7, 2025 Uncategorized

Topologically-crosslinked hydrogels based on γ-cyclodextrins

Biomimetic strategies are increasingly the focus of materials scientists looking to improve or invent new materials. Topology is an important

Continue reading

April 1, 2024 CD derivatives / Non-pharma applications / Pharma applications

Preparation and Application of Polyrotaxane Cross-Linking Agent Based on Cyclodextrin in Gel Materials Field

The cross-linking point of a conventional chemical cross-linking agent is fixed. Therefore, gels that are prepared with a conventional cross-linking

Continue reading

January 3, 2024 Analysis / Non-pharma applications

Reinforced double-threaded slide-ring networks for accelerated hydrogel discovery and 3D printing

Stretchable slide-ring hydrogels are typically soft because of an elasticity-toughness trade-off. Herein, Ke et al. have developed crystalline-domain-reinforced double-threaded slide-ring

Continue reading

October 19, 2023 Uncategorized

Polymerizable rotaxane hydrogels for three-dimensional printing fabrication of wearable sensors

While hydrogels enable a variety of applications in wearable sensors and electronic skins, they are susceptible to fatigue fracture during

Continue reading

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment
  • Lanosterol eye drops for cataract treatment
  • Smart Materials and Surfaces - SMS 2026 International Conference
  • Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
  • Comparative evaluation of lyophilized voriconazole formulations marketed in European Union

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...